Abstract
Retraction: Histone Deacetylase Inhibitors Sensitize Prostate Cancer Cells to Agents that Produce DNA Double-Strand Breaks by Targeting Ku70 Acetylation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have